Patient Characteristics, Treatment Patterns And Incidence Of Events (Discontinuation, Persistence, Key Primary Clinical Outcomes) In NVAF Patients Initiating OAC Therapy In Colombia

NCT04234698 · clinicaltrials.gov ↗
COMPLETED
Status
2076
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Pfizer